Skip to main content
. 2020 Jul 15;10:11676. doi: 10.1038/s41598-020-68360-0

Table 2.

Comparison of the PK primary and secondary endpoints in the PK set.

IBI301 (n = 82) Rituximab (n = 89) Geometric mean ratio (IBI301/rituximab) and 90% CI
AUC0-inf (day × µg/mL) 3,420 (978) 3,769 (1,005) 0.91 (0.85, 0.97)
AUC0-t (day × µg/mL) 3,226 (821) 3,534 (825) 0.91 (0.86, 0.97)
Cmax (µg/mL) 257 (58) 266 (55) 0.96 (0.92, 1.01)

Data are expressed as mean ± SD.

AUC area under the curve, Cmax maximum serum concentration, PK pharmacokinetics.